Autoimmune diseases: MIF as a therapeutic target

被引：68
作者：
Greven, Dorothee [1 ]
Leng, Lin [2 ]
Bucala, Richard [2 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands
[2] Yale Univ, Rheumatol Sect, New Haven, CT 06510 USA
来源：
EXPERT OPINION ON THERAPEUTIC TARGETS | 2010年 / 14卷 / 03期
关键词：
MIGRATION-INHIBITORY FACTOR; JUVENILE IDIOPATHIC ARTHRITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; FACTOR GENE POLYMORPHISM; INNATE IMMUNE-RESPONSES; RHEUMATOID-ARTHRITIS; REGULATORY ROLE; PROINFLAMMATORY FUNCTION; PROMOTER POLYMORPHISMS; CRYSTAL-STRUCTURE;
D O I：
10.1517/14728220903551304
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Areas covered in this review: Our aim is to discuss MIF-directed therapies as a novel therapeutic approach. The review covers literature from the past 10 years. What the reader will gain: MIF inhibition has been shown to be efficacious in many experimental and pre-clinical studies of autoimmune inflammatory diseases. The close regulatory relationship between MIF and glucocorticoids makes therapeutic antagonism of MIF a potential steroid-sparing therapy in patients with refractory autoimmune diseases. Take home message: We expect that MIF antagonism by either small-molecule- or antibody-based approaches will find wide application in the treatment of autoimmune inflammatory diseases. Such therapy also may be informed by the MIF genotype of affected patients.
引用
收藏
页码：253 / 264
页数：12
相关论文
共 50 条
  • [41] Therapeutic Potential of HO-1 in Autoimmune Diseases
    Li, Bao-Zhu
    Guo, Biao
    Zhang, Hai-Yan
    Liu, Juan
    Tao, Sha-Sha
    Pan, Hai-Feng
    Ye, Dong-Qing
    INFLAMMATION, 2014, 37 (05) : 1779 - 1788
  • [42] P2X7 receptor: A potential therapeutic target for autoimmune diseases
    Cao, Fan
    Hu, Li-Qin
    Yao, Shu-Ran
    Hu, Yan
    Wang, De-Guang
    Fan, Yin-Guang
    Pan, Gui-Xia
    Tao, Sha-Sha
    Zhang, Qin
    Pan, Hai-Feng
    Wu, Guo-Cui
    AUTOIMMUNITY REVIEWS, 2019, 18 (08) : 767 - 777
  • [43] Modern Therapeutic Strategies for Autoimmune Diseases
    Tyndall, Alan
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (29) : 4508 - 4512
  • [44] Interleukin-13: A promising therapeutic target for autoimmune disease
    Mao, Yan-Mei
    Zhao, Chan-Na
    Leng, Jing
    Leng, Rui-Xue
    Ye, Dong-Qing
    Zheng, Song Guo
    Pan, Hai-Feng
    CYTOKINE & GROWTH FACTOR REVIEWS, 2019, 45 : 9 - 23
  • [45] Carbonic anhydrase III: A new target for autoantibodies in autoimmune diseases
    Robert-Pachot, Magali
    Desbos, Agnes
    Moreira, Annick
    Becchi, Michel
    Tebib, Jacques
    Bonnin, Michel
    Aitsiselmi, Tarik
    Bienvenu, Jacques
    Fabien, Nicole
    AUTOIMMUNITY, 2007, 40 (05) : 380 - 389
  • [46] Circadian clock genes as promising therapeutic targets for autoimmune diseases
    Xiang, Kun
    Xu, Zhiwei
    Hu, Yu-Qian
    He, Yi-Sheng
    Wu, Guo-Cui
    Li, Tian-Yu
    Wang, Xue-Rong
    Ding, Li-Hong
    Zhang, Qin
    Tao, Sha-Sha
    Ye, Dong-Qing
    Pan, Hai-Feng
    Wang, De-Guang
    AUTOIMMUNITY REVIEWS, 2021, 20 (08)
  • [47] SOCS signaling in autoimmune diseases: Molecular mechanisms and therapeutic implications
    Liang, Yan
    Xu, Wang-Dong
    Peng, Hui
    Pan, Hai-Feng
    Ye, Dong-Qing
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (05) : 1265 - 1275
  • [48] Circular RNAs: Potential biomarkers and therapeutic targets for autoimmune diseases
    Zhao, Ren-Jie
    Zhang, Wan-Ying
    Fan, Xing-Xing
    HELIYON, 2024, 10 (01)
  • [49] Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
    Beeton, Christine
    Wulff, Heike
    Standifer, Nathan E.
    Azam, Philippe
    Mullen, Katherine M.
    Pennington, Michael W.
    Kolski-Andreaco, Aaron
    Wei, Eric
    Grino, Alexandra
    Counts, Debra R.
    Wang, Ping H.
    LeeHealey, Christine J.
    Andrews, Brian S.
    Sankaranarayanan, Ananthakrishnan
    Homerick, Daniel
    Roeck, Werner W.
    Tehranzadeh, Jamshid
    Stanhope, Kimber L.
    Zimin, Pavel
    Havel, Peter J.
    Griffey, Stephen
    Knaus, Hans-Guenther
    Nepom, Gerald T.
    Gutman, George A.
    Calabresi, Peter A.
    Chandy, K. George
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (46) : 17414 - 17419
  • [50] Therapeutic potential of enhancer of zeste homolog 2 in autoimmune diseases
    Yang, Yue-Xin
    Shen, Hui-Hui
    Cao, Fan
    Xie, Liang-Yu
    Zhu, Guang-Lin
    Sam, Napoleon Bellua
    Wang, De-Guang
    Pan, Hai-Feng
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (12) : 1015 - 1030
12345